AZoLifeSciences on MSN
Synthetic RNA platform converts viral replication into detectable cellular signals
The technology, called the Viral-Engineered RNA-based Activation System (VERAS), hijacks the virus's own replication ...
Cohesity is offering up to 72.25 percent off select data protection and replication software to federal agencies.
2026 is highlighted as the year of the singularity with Elon Musk warning of underestimated impacts; conversations with him ...
DNA doesn’t just sit still inside our cells — it folds, loops, and rearranges in ways that shape how genes behave.
Members of a new class of antivirals are being tested in U.S. clinical trials, and one has gained approval in Japan, but how ...
ETX-19477 is a potent, selective inhibitor of poly (ADP-ribose) glycohydrolase (PARG), an enzyme that plays a role in the DNA ...
The L7 is the first full-size bipedal humanoid robot in China to combine large-scale dynamic motion with fine manipulation. At CES 2026, L7 demonstrates ultra-low-latency full-body teleoperation, ...
A Northwestern Medicine study has revealed a previously unknown connection between two fundamental cellular processes, ...
1don MSN
Replication efforts suggest 'smoking gun' evidence isn't enough to prove quantum computing claims
A group of scientists, including Sergey Frolov, professor of physics at the University of Pittsburgh, and co-authors from ...
Topline data were announced from two phase 3 studies evaluating bepirovirsen for the treatment of chronic hepatitis B.
An HIV-derived nucleoside therapy now treats rare genetic diseases by restoring mitochondrial DNA and improving muscle ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results